Legionella Testing Market Size, Revenue, Forecast Report 2026 to 2035
What is Legionella Testing Market Size?
The Legionella Testing Market Size is valued at USD 371.83 Mn in 2025 and is predicted to reach USD 799.65 Mn by the year 2035 at a 8.0% CAGR during the forecast period for 2026 to 2035.
Legionella Testing Market Size, Share & Trends Analysis Report By Test Type (Culture, Urine Antigen Test (UAT), Direct Fluorescent Antibody (DFA) Test), By End-Use (Hospitals & Clinics, Diagnostics Laboratories, Water Treatment Industries), By Region, And By Segment Forecasts, 2026 to 2035.
Legionella Testing Market Key Takeaways:
|
Legionella testing detects the presence of the bacterium Legionella pneumophila and other related species in water sources. The testing procedure is critical for identifying potential Legionella contamination sources and averting Legionnaires' disease outbreaks. Legionella testing procedures have become more efficient and accurate as testing technology has advanced.
PCR-based testing and next-generation sequencing (NGS) are two technologies that have gained popularity as a result of their shorter turnaround times and ability to deliver more detailed information. The technologies that power molecular diagnostics are fast improving to aid in the fight against rapidly spreading infectious disease pandemics. The traditional Legionella testing method based on microbial culture technology is time-consuming and labor-intensive.
However, certain industries, such as hospitality and tourism, were significantly affected by the pandemic, leading to reduced occupancy or temporary closures of hotels, resorts, and other facilities. These changes could have influenced the demand for Legionella testing in these sectors.
Competitive Landscape:
Some major key players in the Legionella Testing Market:
- Thermo Fisher Scienific, Inc. (US)
- Merck KGaA (Germany)
- Becton, Dickinson, and Company (US)
- Roche Diagnostics (Switzerland)
- Pall Corporation (US)
- Pro-lab Diagnostics Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Alere Inc. (Abbott Rapid Diagnostics)
- Eiken Chemical Co. Ltd.
- Hologic Inc.
- QIAGEN
- Takara Bio Inc.
- Environmental Safety Technologies Inc.
- Hydrosense
- Accepta Ltd.
- LuminUltra Technologies Ltd.
- Pro-Lab Diagnostics Inc.
- BioAlert Solutions
- Pacific Water Technology
- Aquacert Ltd.
- DTK Water
- Sens Solutions
- Genomadix Inc.
- Phigenics LLC
Market Segmentation:
The Legionella Testing Market is segmented on the basis of test type and end-use. Acording to test type, the market is segmented as culture, Urine Antigen Test (UAT), and Direct Fluorescent Antibody (DFA) Test. The end-user segment includes hospitals & clinics, diagnostics laboratories, and water treatment industries.
Based On Test Type, The Urine Antigen Test (UAT)Segment Is Accounted As A Major Contributor In The Legionella Testing Market
The Urine Antigen Test (UAT) category is expected to hold a major share of the global Legionella Testing Market in 2022. This is the most widely used laboratory test for detecting legionella bacteria in urine. It can offer results on the same day as the sample collection, as opposed to culture media approaches, which take 7 to 8 days. Furthermore, it is a low-cost test that is more popular among people from underdeveloped or developing countries. Rapidly rising PCR technology to dominate the market with a higher CAGR over the forecast period due to the maximum selectivity and specificity of the test.
The Diagnostics Laboratories Segment Witnessed Growth At A Rapid Rate
The diagnostics laboratories segment is projected to grow at a rapid rate in the global Legionella Testing Market. This is due to the increasing prevalence of Legionnaire disease, more awareness, and increased penetration of improved assays for Legionella infection detection. This dominance is expected to persist throughout the projection period. The other segment, which encompasses environmental testing in addition to clinical Legionella bacteria testing, is expected to grow rapidly due to the advent of onsite testing methodologies and the enforcement of rigorous rules for routine water check-ups.
In The Region, The North America Legionella Testing Market Holds A Significant Revenue Share
The North America Legionella Testing Market is expected to register the topmost market share in terms of revenue in the near future. The market in this region is distinguished by high Legionnaire disease diagnostic rates, the presence of world-class healthcare infrastructure, high illness awareness, and severe water testing requirements.
The presence of a large geriatric population that is readily infected, together with the high risk of mortality owing to associated pneumonia among such patients, prioritizes Legionella testing in countries such as the United States, which is adding momentum to the regional market. The Asia-Pacific market is expected to grow at a substantial CAGR within the forecast period due to economic development, an empowered healthcare industry, and increased awareness of available test products in the region.
Legionella Testing Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 371.83 Mn |
| Revenue Forecast In 2035 | USD 799.65 Mn |
| Growth Rate CAGR | CAGR of 8.0 % from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Test Type, End-Use |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Biomérieux, Merck KGaA, Quidel Corporation, Abbott Laboratories, Aquacert Ltd, Phigenics, LLC, Pall Corporation, and Evoqua Water Technologies LLC |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Legionella Testing Market-
Legionella Testing Market By Test Type-
- Culture
- Urine Antigen Test (UAT)
- Direct Fluorescent Antibody (DFA) Test
Legionella Testing Market By End-Use-
- Hospitals & Clinics
- Diagnostics Laboratories
- Water Treatment Industries
Legionella Testing Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Legionella Testing Market Size is valued at USD 371.83 Mn in 2025 and is predicted to reach USD 799.65 Mn by the year 2035.
Legionella Testing Market expected to grow at a 8.0% CAGR during the forecast period for 2026-2035.
Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Biomérieux, Merck KGaA, Quidel Corporation, Abbott Laboratories, Aquacert Ltd, Phigenics
Legionella Testing Market is segmented on the basis of test type and end-use, culture, Urine Antigen Test (UAT), and Direct Fluorescent Antibody (DFA) Test.
North American region is leading the Legionella Testing Market.